Aspirin has been associated with a reduced risk of colorectal cancer, and possibly of a few other digestive tract cancers. The quantification of risk reduction and the optimal dose and duration of aspirin use for the prevention of colorectal and other digestive tract cancers remains unclear.
Aspirin and the risk of colorectal and other digestive tract cancers: an updated meta-analysis through 2019 / C. Bosetti, C. Santucci, S. Gallus, M. Martinetti, C. La Vecchia. - In: ANNALS OF ONCOLOGY. - ISSN 0923-7534. - 31:5(2020 May), pp. 558-568. [10.1016/j.annonc.2020.02.012]
Aspirin and the risk of colorectal and other digestive tract cancers: an updated meta-analysis through 2019
C. Santucci;C. La Vecchia
2020
Abstract
Aspirin has been associated with a reduced risk of colorectal cancer, and possibly of a few other digestive tract cancers. The quantification of risk reduction and the optimal dose and duration of aspirin use for the prevention of colorectal and other digestive tract cancers remains unclear.
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Aspirin colorectal Bosetti 19.pdf
accesso aperto
Tipologia:
Publisher's version/PDF
Dimensione
1.75 MB
Formato
Adobe PDF
|
1.75 MB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
